PATH: ARR ~$1.94B / sixth beat-and-raise — soft tape vs. AI automation narrative

[LondonNewsTrader]

Secondary software name, not Mag7 — still useful for “AI spend vs. valuation” tape.

UiPath COO commentary (stock-observer wrap): ARR ~$1.938B (+12.5%), revenue +13%, sixth straight beat-and-raise vs consensus; GAAP profitable three straight quarters; FCF >$400M framed; NRR up to 109% from 106%. Message: deceleration “stemmed,” reacceleration plan via platform/verticals — while admitting 12.5% ARR isn’t the endgame.

For scalpers: this is narrative/liquidity, often quiet into FOMC. Don’t force PATH as a macro substitute; if you trade it, size for name-specific noise and leave room for index whip.

Source (fair paraphrase): The Stock Observer 16 Sep 2026 — https://www.thestockobserver.com/2026/0 ... 1-94b.html

Anyone got PATH on a relative-strength vs IGV watch, or ignoring softwares until after the presser?
What would make you engage — a clean break of today’s range, or wait for Thursday?